4,036 Shares in DocuSign, Inc. (NASDAQ:DOCU) Purchased by Certuity LLC

Certuity LLC bought a new stake in DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 4,036 shares of the company’s stock, valued at approximately $363,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Itau Unibanco Holding S.A. purchased a new stake in shares of DocuSign in the 3rd quarter valued at $28,000. Brooklyn Investment Group purchased a new position in shares of DocuSign during the third quarter worth $33,000. Modus Advisors LLC acquired a new position in DocuSign during the fourth quarter valued at $36,000. Reston Wealth Management LLC purchased a new stake in DocuSign in the third quarter valued at $47,000. Finally, Avior Wealth Management LLC grew its position in DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after purchasing an additional 145 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on DOCU. UBS Group boosted their price objective on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Royal Bank of Canada reissued a “sector perform” rating and issued a $90.00 price target (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. Citigroup raised their price objective on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research note on Friday, December 6th. Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a report on Friday, December 6th. Finally, Morgan Stanley increased their price target on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $92.45.

DocuSign Stock Up 0.4 %

Shares of NASDAQ DOCU opened at $88.29 on Thursday. The firm has a market cap of $17.84 billion, a price-to-earnings ratio of 18.20, a price-to-earnings-growth ratio of 7.56 and a beta of 0.89. The company’s 50-day simple moving average is $92.94 and its 200-day simple moving average is $74.95. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.

Insider Buying and Selling

In related news, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the transaction, the director now directly owns 906,430 shares of the company’s stock, valued at approximately $87,959,967.20. This represents a 39.08 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 7,763 shares of DocuSign stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the sale, the chief executive officer now directly owns 100,062 shares in the company, valued at approximately $8,058,993.48. This trade represents a 7.20 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 685,773 shares of company stock worth $66,032,726. Insiders own 1.66% of the company’s stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.